Co-diagnostics, inc. to present at 29th international biodetection technologies virtual conference

Salt lake city , june 28, 2022 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx,"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be presenting this week at the 29th international biodetection technologies conference, held virtually june 28-29, 2022. the biodetection technologies conference is an internationally recognized meeting for experts in detection & identification of biological threats, which this year plans to address the key topics in detection and present the latest r&d and technological innovation in ready-to-market systems.
CODX Ratings Summary
CODX Quant Ranking